Copyright
©The Author(s) 2022.
World J Gastrointest Surg. Aug 27, 2022; 14(8): 809-820
Published online Aug 27, 2022. doi: 10.4240/wjgs.v14.i8.809
Published online Aug 27, 2022. doi: 10.4240/wjgs.v14.i8.809
Variable | Total (n = 103) | Survival (n = 55) | Death (n = 48) | P value |
Age (yr) (mean ± SD) | 68.3 ± 11.3 | 68.5 ± 10.6 | 68.0 ± 12.3 | 0.811 |
BMI | 23.8 ± 3.7 | 23.5 ± 2.9 | 24.3 ± 4.6 | 0.323 |
Sex, n (%) | 0.495 | |||
Male | 39 (37.9) | 23 (59.0) | 16 (41.0) | |
Female | 64 (62.1) | 32 (50.0) | 32 (50.0) | |
Comorbidities, n (%) | ||||
Diabetes mellitus | 56 (54.4) | 32 (57.1) | 24 (42.9) | 0.527 |
Hypertension | 65 (63.1) | 35 (53.8) | 30 (46.2) | 1.000 |
Coronary artery disease | 18 (17.5) | 10 (55.6) | 8 (44.4) | 1.000 |
Heart failure | 11 (10.7) | 6 (54.5) | 5 (45.5) | 1.000 |
Atrial fibrillation | 5 (4.9) | 2 (40.0) | 3 (60.0) | 0.662 |
Prior stroke | 15 (14.6) | 10 (66.7) | 5 (33.3) | 0.404 |
Peripheral arterial occlusive disease | 10 (9.7) | 4 (40.0) | 6 (60.0) | 0.508 |
Cirrhosis | 3 (2.9) | 1 (33.3) | 2 (66.7) | 0.597 |
Peptic ulcer disease | 24 (23.3) | 11 (45.8) | 13 (54.2) | 0.539 |
Chronic obstructive pulmonary disease | 3 (2.9) | 1 (33.3) | 2 (66.7) | 0.597 |
Malignancy | 13 (12.6) | 8 (61.5) | 5 (38.5) | 0.740 |
Immunosuppressive status | 2 (1.9) | 1 (50.0) | 1 (50.0) | 1.000 |
RRT modality | ||||
Hemodialysis | 100 (97.1) | 55 (55.0) | 45 (45.0) | 0.098 |
Peritoneal dialysis | 8 (7.8) | 1 (12.5) | 7 (87.5) | 0.024a |
Characteristics | Total (n = 103) | Survival (n = 55) | Death (n = 48) | P value |
Surgery delay (d) (mean ± SD) | 2.6 ± 3.1 | 2.3 ± 2.8 | 2.9 ± 3.5 | 0.296 |
Complications, n (%) | ||||
Shock | 87 (84.5) | 41 (47.1) | 46 (52.9) | 0.007a |
Laboratory data | ||||
Hospital day 1 | ||||
WBC (k/μL) | 12.86 ± 6.21 | 11.69 ± 5.49 | 14.21 ± 6.74 | 0.041a |
Hemoglobin (g/dL) | 11.06 ± 2.40 | 11.22 ± 2.30 | 10.88 ± 2.53 | 0.476 |
Platelet (k/μL) | 195.47 ± 76.10 | 189.76 ± 65.39 | 202.00 ± 87.03 | 0.418 |
PMN (%) | 82.36 ± 10.74 | 80.87 ± 11.59 | 84.08 ± 9.50 | 0.126 |
Lymphocytes (%) | 9.28 ± 6.10 | 10.12 ± 6.34 | 8.32 ± 5.72 | 0.132 |
CRP (mg/L) | 180.12 ± 138.86 | 167.23 ± 136.09 | 193.60 ± 142.03 | 0.377 |
Potassium (mEq/L) | 4.47 ± 1.02 | 4.71 ± 1.08 | 4.19 ± 0.89 | 0.008a |
Albumin (g/dL) | 2.82 ± 0.59 | 2.91 ± 0.41 | 2.70 ± 0.74 | 0.080 |
Total bilirubin (mg/dL) | 0.86 ± 0.61 | 0.78 ± 0.34 | 0.94 ± 0.79 | 0.230 |
Hospital day 7 | ||||
WBC count (k/μL) | 11.87 ± 6.94 | 10.05 ± 5.04 | 13.96 ± 8.19 | 0.004a |
Hemoglobin (g/dL) | 9.56 ± 1.74 | 9.39 ± 1.76 | 9.75 ± 1.72 | 0.297 |
Platelets (k/μL) | 159.35 ± 94.81 | 173.94 ± 72.26 | 142.94 ± 113.62 | 0.099 |
PMN (%) | 79.71 ± 11.77 | 78.69 ± 8.83 | 80.90 ± 14.49 | 0.347 |
Lymphocytes (%) | 10.16 ± 8.08 | 10.19 ± 5.60 | 10.13 ± 10.33 | 0.975 |
CRP (mg/L) | 157.71 ± 89.16 | 119.34 ± 81.27 | 191.94 ± 82.54 | 0.000a |
Potassium (mEq/L) | 4.08 ± 0.85 | 3.94 ± 0.68 | 4.24 ± 1.00 | 0.075 |
Albumin (g/dL) | 2.50 ± 0.43 | 2.50 ± 0.47 | 2.50 ± 0.41 | 0.977 |
Total bilirubin (mg/dL) | 1.62 ± 1.93 | 1.11 ± 1.75 | 2.05 ± 2.00 | 0.053 |
Echocardiographyin hospital | ||||
LVEF | 0.65 ± 0.13 | 0.66 ± 0.11 | 0.62 ± 0.16 | 0.199 |
Etiology of mesenteric ischemia, n (%) | ||||
Arterial embolism | 0 (0) | 0 (0.0) | 0 (0.0) | NA |
Arterial thrombosis | 5 (4.9) | 2 (40.0) | 3 (60.0) | 0.664 |
Venous thrombosis | 0 (0) | 0 (0.0) | 0 (0.0) | NA |
Nonocclusive | 97 (95.1) | 52 (53.6) | 45 (46.4) | 0.664 |
Bowel resection site, n (%) | ||||
Jejunum | 28 (27.5) | 12 (42.9) | 16 (57.1) | 0.302 |
Ileum | 82 (80.4) | 48 (58.5) | 34 (41.5) | 0.041a |
Colon | 42 (41.2) | 18 (42.9) | 24 (57.1) | 0.132 |
Rectum | 2 (2.0) | 0 (0.0) | 2 (100.0) | 0.219 |
Bowel resection length (cm) (mean ± SD) | ||||
Small intestine | 65.39 ± 58.86 | 59.84 ± 48.80 | 71.64 ± 68.43 | 0.314 |
Colon | 14.23 ± 23.93 | 11.88 ± 24.30 | 16.88 ± 23.47 | 0.294 |
Total | 78.85 ± 58.36 | 70.41 ± 48.18 | 88.52 ± 67.43 | 0.117 |
Variable | Protective measurement univariate | Protective measurement multivariate |
Hazard ratio (95%CI) | Hazard ratio (95%CI) | |
Surgery delay < 4.5 d | 2.63 (1.11-6.25)a | 2.70 (0.69-10.0) |
No shock | 2.86 (1.49-5.26)a | 1.67 (0.33-8.33) |
Potassium level in hospital on day 1 | 1.44 (1.13-1.83)a | 1.78(1.25-2.54)a |
WBC count in hospital on day 7 | 0.93 (0.88-0.98)a | 0.94 (0.85-1.03) |
Neutrophil count in hospital on day 7 | 0.96 (0.93-0.99)a | 0.92 (0.84-1.00)a |
Lymphocyte count in hospital on day 7 | 1.06 (1.01-1.11)a | 0.89 (0.76-1.04) |
CRP level in hospital on day 7 | 0.99 (0.99-1.00)a | 0.99 (0.99-1.00) |
No resection of colon | 2.08 (1.15-3.85)a | 2.70 (1.05-7.14)a |
Total resection length < 110 cm | 2.33 (1.18-4.76)a | 3.85 (1.41-11.11)a |
- Citation: Liau SK, Kuo G, Chen CY, Lu YA, Lin YJ, Lee CC, Hung CC, Tian YC, Hsu HH. Identifying survival protective factors for chronic dialysis patients with surgically confirmed acute mesenteric ischemia. World J Gastrointest Surg 2022; 14(8): 809-820
- URL: https://www.wjgnet.com/1948-9366/full/v14/i8/809.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v14.i8.809